Physician Partnership Track: Buy-In, Equity, and What It Actually Means for Your Pay

The two-phase model: associate to owner

Most private-practice partnership tracks follow a familiar arc: you join as an associate — essentially an employed physician — while the group evaluates fit and you build your patient base. After a defined period, typically two to five years, you become eligible to buy in to the practice as a co-owner. What you own, how the price is set, and what your pay looks like on the other side of that transition are three entirely separate questions that the phrase "partnership track" does not answer on its own.

Hospital-employed positions do not have a comparable path. If you work for a health system, you remain an employee regardless of seniority or title. Partnership — in the sense of equity ownership with profit distributions — exists only in practices organized as partnerships, limited liability companies (LLCs), or professional corporations (PCs). Understanding what you are buying before you commit the time and money is the core job of due diligence.

What "partner" actually means — three things to define before you sign

Many physicians accept a partnership offer assuming it includes everything the word implies. It often does not. There are three distinct components to true partnership, and any one of them can be absent:

• Equity stake. A fractional ownership interest in the practice entity — its assets, contracts, and, critically, its value if the practice is ever sold. An equity stake is measured in percentage or shares. Without it, you are not an owner in any meaningful legal sense.
• Profit distribution rights. The right to receive periodic payouts of the practice's net earnings in proportion to your ownership percentage. Some arrangements grant profit sharing without conferring a formal equity stake; these can look and feel like partnership while giving you nothing on a sale event.
• Governance and voting rights. The ability to vote on major decisions — hiring partners, signing leases, entering management contracts, accepting an acquisition offer. A minority partner with no effective vote is subject to the same decisions as an employee, with an added buy-in price tag.

When a group says "partnership," ask immediately: what does partner status include in writing — equity percentage, a right to distributions, and a vote? Get the answers in the partnership agreement itself, not in a conversation with a recruiter or a senior partner. Verbal promises about future ownership are not enforceable.

How practices are valued and buy-ins are priced

The buy-in price is the amount you pay (over time or upfront) to acquire your ownership percentage. It derives from the practice's overall valuation, which can be calculated in several ways — and the method chosen makes a significant difference in what you pay.

Tangible net asset value (TNAV) counts only the physical and liquid assets the practice actually owns: medical equipment, accounts receivable, cash, furniture, and any real estate. It ignores the intangible value of established referral relationships, long-standing payer contracts, and the practice's reputation. TNAV tends to produce the lowest valuations and is considered the most physician-favorable method for a buy-in.

Goodwill-inclusive valuation adds an intangible component on top of tangible assets. Goodwill is supposed to capture the earning power that would take a new practice years to replicate. The problem is that goodwill in a physician practice is partially personal — it walks out the door when senior partners retire — and its value is highly subjective. Practices that anchor their valuation to goodwill often end up asking new partners to pay for the relationships of physicians who may not practice much longer. This is the most common source of inflated buy-in prices.

EBITDA-based valuation applies a multiple to the practice's earnings before interest, taxes, depreciation, and amortization. Multiples vary with specialty, practice size, payer mix, and geography. This method is now common in markets where private equity has established benchmark sale prices; it tends to produce the highest valuations and can mean a buy-in price that bears little relationship to what individual physician earnings actually support.

What to ask: Which valuation method does the group use, who performed the valuation, and when was the most recent one done? Ask to see audited financial statements — not just summary numbers — covering at least the past three years. Compare the buy-in price to your share of realistic projected annual distributions. If the math does not show you recovering the buy-in within a reasonable number of years through distributions that exceed what you would earn as an employee, the price is too high.

How you pay for it

A buy-in rarely requires a single lump-sum check, though that option exists. The three most common financing structures are:

• Practice loan. The group lends you the buy-in amount, and you repay it — with interest — from your future distributions. You become an equity partner immediately on closing, but your net distributions are reduced by debt service until the loan is repaid. Confirm the interest rate and whether it is fixed.
• Sweat equity. The group redirects a defined portion of your bonus or production payments toward the buy-in balance each year. You do not receive that money as cash; it accumulates as equity. Your take-home pay is lower than a comparably productive employee's during the buy-in period, sometimes for several years.
• Upfront personal financing. You fund the buy-in with personal savings or a physician practice loan from an outside lender. This transfers all interest cost to you, but it delivers full partner status immediately without ongoing debt to the practice.

In every structure, clarify what happens to your equity and any amounts already paid if you leave before the buy-in is complete. Some agreements treat mid-track departures as forfeitures; others return the paid-in amount without interest. The departure terms deserve as much scrutiny as the buy-in price itself.

How partner compensation differs from associate pay

As an associate, your pay is typically a salary or a base draw plus a production-based bonus — often tied to your own wRVU output or collections. As a partner, the structure usually changes in a meaningful way.

Partners typically receive a regular partner draw — a predictable periodic payment that functions like a salary — plus profit distributions tied to the practice's overall financial performance. The draw may be lower than your associate salary; distributions are intended to make up the difference and then some. But distributions depend on the practice's profitability, which depends on everything: payer rates, overhead management, how productively all the partners work, and whether the group is adding staff or making capital investments. A slow year for the whole practice is a slow year for your distributions regardless of your personal production numbers.

Some practices, especially smaller ones, use an "eat what you kill" allocation, where each partner's earnings are calculated by subtracting their proportional share of overhead from the revenues attributed to their own patients. This model closely mirrors associate pay — you are still compensated on individual productivity — but ownership adds the benefit (or risk) of any residual after overhead is covered.

The honest truth about partner pay is that the financial premium over employed compensation may not appear for several years after buy-in. You pay for equity during the buy-in period, distributions in early partner years may closely resemble what you were earning as an associate, and the upside comes later — from both growing distributions and from the equity value you hold if the practice is ever sold.

The private equity risk every associate must understand

Private equity firms have been acquiring physician practices across most specialties at a rapid pace for the past decade, and the pace has not slowed. The structure typically works through a management services organization (MSO): a PE-backed entity acquires the non-clinical administrative and management operations of the practice, leaving the clinical entity nominally physician-owned to comply with state corporate practice of medicine laws. From a physician's day-to-day perspective, however, the group's strategic decisions are effectively controlled by the PE ownership.

The specific risk for physicians on a partnership track is this: if the practice is acquired before you complete the track and vest as an equity partner, your promised path to ownership can disappear. The acquisition agreement typically restructures the existing partnership and replaces it with an employment contract — sometimes with a token equity grant in the MSO entity — and any oral promises made by prior partners about future ownership are not legally binding on the acquiring entity.

This is not theoretical. It is a documented pattern in gastroenterology, dermatology, ophthalmology, orthopedic surgery, and primary care. The safeguards are contractual: ask directly whether the partnership agreement contains anti-dilution provisions, a right to approve a sale, or accelerated vesting on a change of control. If the group cannot point you to specific language protecting associates on a sale event, weigh that silence carefully.

Questions to ask before you commit to a track

A partnership offer deserves methodical scrutiny. Before accepting any track, you should be able to answer each of these in writing:

• Exactly what does "partner" include? Equity percentage, profit distribution rights, and a governance vote — confirmed in a draft partnership agreement, not a verbal summary.
• How is the practice valued, who did the valuation, and how recently? Ask for the valuation report and audited financials for the past three years. Calculate what your buy-in price implies about the practice's earnings multiple.
• What are historical partner distributions, per year, for the past three years? Not projected; actual. Compare them to what you would earn as a productive employed physician in the same specialty and market.
• What happens if the practice is sold before I complete the track? Look for written change-of-control provisions that either accelerate your vesting or give you the right to exit cleanly with any capital already contributed.
• Who finances the buy-in, at what interest rate, and what are the departure terms if I leave mid-track? Confirm in writing whether paid-in amounts are forfeited or returned on departure before full vesting.